World TB Day - Emerging Infectious Disease journal - CDC

World TB Day - Emerging Infectious Disease journal - CDC







Tuberculosis Spotlight

World TB Day commemorates the discovery of the tuberculosis (TB) bacterium (Mycobacterium tuberculosis) by Dr. Robert Koch on March 24, 1882. World TB day is commemorated on this date each year to raise awareness among the public and policy makers that tuberculosis remains an epidemic in most parts of the world, and a public health problem in developed countries, causing the deaths of about one and a half million people each year. Koch's discovery opened the way towards diagnosing and curing TB.

World TB Day provides the opportunity to raise awareness about TB-related problems and solutions and to support worldwide TB-control efforts. While great strides have been made to control and cure TB, people still get sick and die from this disease in our country. Much more needs to be done to eliminate this disease.

The theme of World TB Day 2016 is “Unite to End TB.”

Click on the links to Emerging Infectious Diseases articles and podcasts below and learn more about the latest information and emerging trends in TB.

Articles

2016

Leveraging Advances in Tuberculosis Diagnosis and Treatment to Address Nontuberculous Mycobacterial Disease
R.M. Raju et al. (Volume 22, Number 3—March 2016)

Tuberculosis Caused by Mycobacterium africanum, United States, 2004–2013
A. Sharma et al. (Volume 22, Number 3—March 2016)

Patient Report and Review of Rapidly Growing Mycobacterial Infection after Cardiac Device Implantation
V.K. Phadke et al. (Volume 22, Number 3—March 2016)

Improved Detection of Tuberculosis and Multidrug-Resistant Tuberculosis among Tibetan Refugees, India
K.L. Dierberg et al. (Volume 22, Number 3—March 2016)

Factors Associated with Loss to Follow-up during Treatment for Multidrug-Resistant Tuberculosis, the Philippines, 2012–2014
T.E. Tupasi et al. (Volume 22, Number 3—March 2016)

Use of Transnational Services to Prevent Treatment Interruption in Tuberculosis-Infected Persons Who Leave the United States
C.A. Tschampl et al. (Volume 22, Number 3—March 2016)

Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia
H.R. Stagg et al. (Volume 22, Number 3—March 2016)

Effects of Response to 2014–2015 Ebola Outbreak on Deaths from Malaria, HIV/AIDS, and Tuberculosis, West Africa
A.S. Parpia et al. (Volume 22, Number 3—March 2016)

Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009–2014
B. Henry et al. (Volume 22, Number 3—March 2016)

Treatment of Mycobacterium abscessus Infection
S.A. Novosad et al. (Volume 22, Number 3—March 2016)

Tuberculosis, Fiji, 2002–2013
L. Pezzoli et al. (Volume 22, Number 3—March 2016)

Medscape CME Activity
Epidemiology of Human Mycobacterium bovis Disease, California, USA, 2003–2011
M. Gallivan et al. (Volume 21, Number 3—March 2015)

Patient Diagnostic Rate as Indicator of Tuberculosis Case Detection, South Africa
M.M. Claassens et al. (Volume 22, Number 3—March 2016)

Far East Scarlet-Like Fever Caused by a Few Related Genotypes of Yersinia pseudotuberculosis, Russia
N.F. Timchenko et al. (Volume 22, Number 3—March 2016)

Monitoring Therapy Compliance of Tuberculosis Patients by using Video-Enabled Electronic Devices
A. Story et al. (Volume 22, Number 3—March 2016)

High Tuberculosis Risk among Medical Trainees, Pune, India
A. Basavaraj et al. (Volume 22, Number 3—March 2016)

Mycobacterium microti Infection in Dairy Goats, France
L. Michelet et al. (Volume 22, Number 3—March 2016)

Mycobacterium orygis–Associated Tuberculosis in Free-Ranging Rhinoceros, Nepal, 2015
J. Thapa et al. (Volume 22, Number 3—March 2016)

Mycobacterium arupense as an Emerging Cause of Tenosynovitis
F. Krapp Lopez et al. (Volume 22, Number 3—March 2016)

Depictions of Heroism in Battle and Anguish from Tuberculosis
T. Chorba et al. (Volume 22, Number 3—March 2016)

Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis
J. Furin et al. (Volume 22, Number 3—March 2016)

Global Introduction of New Multidrug-Resistant Tuberculosis Drugs—Balancing Regulation with Urgent Patient Needs
T. Sullivan et al. (Volume 22, Number 3—March 2016)

African Buffalo Movement and Zoonotic Disease Risk across Transfrontier Conservation Areas, Southern Africa
A. Caron et al. (Volume 22, Number 2—February 2016)

2015

Achievements in and Challenges of Tuberculosis Control in South Korea
J. Han Kim et al. (Volume 21, Number 11—November 2015)

Epidemiology of Primary Multidrug-Resistant Tuberculosis, Vladimir Region, Russia
J.V. Ershova et al. (Volume 21, Number 11—November 2015)

Histoplasmosis in HIV-Infected Persons, Yaoundé, Cameroon
C.E. Mandengue et al. (Volume 21, Number 11—November 2015)

Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen
J. Achar et al. (Volume 21, Number 11—November 2015)

Mycobacterium sherrisii Pulmonary Disease, Burkina Faso
E. Borroni et al. (Volume 21, Number 11—November 2015)

Co-infection with Drug-Susceptible and Reactivated Latent Multidrug-Resistant Mycobacterium tuberculosis
L. Pérez-Lago et al. (Volume 21, Number 11—November 2015)

Increase in Lymphadenitis Cases after Shift in BCG Vaccine Strain
G. Kuchukhidze et al. (Volume 21, Number 9—September 2015)

Risk for Mycobacterial Disease among Patients with Rheumatoid Arthritis, Taiwan, 2001–2011
T.L. Liao et al. (Volume 21, Number 8—August 2015)

Seasonal Patterns of Buruli Ulcer Incidence, Central Africa, 2002–2012
J. Landier et al. (Volume 21, Number 8—August 2015)

Multidrug-Resistant Tuberculosis in Patients for Whom First-Line Treatment Failed, Mongolia, 2010–2011
C.C. Dobler et al. (Volume 21, Number 8—August 2015)

Fatal Nosocomial MDR TB Identified through Routine Genetic Analysis and Whole-Genome Sequencing
O.M. Williams et al. (Volume 21, Number 6—June 2015)

Multidrug-Resistant Tuberculosis in Europe, 2010–2011
G. Günther et al. (Volume 21, Number 3—March 2015)

Prisons as Reservoir for Community Transmission of Tuberculosis, Brazil
F.P.C. Sacchi et al. (Volume 21, Number 3—March 2015)

Increased Risk for Multidrug-Resistant Tuberculosis in Migratory Workers, Armenia
N. Truzyan et al. (Volume 21, Number 3—March 2015)

Characteristics of Tuberculosis Cases that Started Outbreaks in the United States, 2002–2011
M.B. Haddad et al. (Volume 21, Number 3—March 2015)

Moxifloxacin Prophylaxis Against MDR TB, New York, New York, USA
L. Trieu et al. (Volume 21, Number 3—March 2015)

Noninvasive Test for Tuberculosis Detection among Primates
T.M. Wolf et al. (Volume 21, Number 3—March 2015)

Buruli Ulcer in Traveler from Suriname, South America, to the Netherlands
W.R. Faber et al. (Volume 21, Number 3—March 2015)

Tuberculosis Microepidemics among Dispersed Migrants, Birmingham, UK, 2004–2013
M.L. Munang et al. (Volume 21, Number 3—March 2015)

Spillover of Mycobacterium bovis from Wildlife to Livestock, South 
Africa
J. Musoke et al. (Volume 21, Number 3—March 2015)

Mycobacterium bovis Infection in Humans and Cats in Same Household, Texas, USA, 2012
K.E.F. Ramdas et al. (Volume 21, Number 3—March 2015)

Red Deer as Maintenance Host for Bovine Tuberculosis, Alpine Region
M. Fink et al. (Volume 21, Number 3—March 2015)

Role of Race/Ethnicity in Pulmonary Nontuberculous Mycobacterial Disease
B.S. Thomas et al. (Volume 21, Number 3—March 2015)

Treatment of Mycobacterium abscessus subsp. massiliense Tricuspid Valve Endocarditis
R.G. Huth et al. (Volume 21, Number 3—March 2015)

Disseminated Mycobacterium tuberculosis in Imported Sooty Mangabey, Thailand
S. Kesdangsakonwut et al. (Volume 21, Number 3—March 2015)

Mycobacterium bovis BCG–Associated Osteomyelitis/Osteitis, Taiwan
N.C. Chiu et al. (Volume 21, Number 3—March 2015)

Multidrug-Resistant Tuberculosis Outbreak in Gaming Centers, Singapore, 2012
C.B.E. Chee et al. (Volume 21, Number 1—January 2015)

2014

HIV-Associated Disseminated Emmonsiosis, Johannesburg, South Africa
W.G. van Hougenhouck-Tulleken et al. (Volume 20, Number 12—December 2014)

Beijing Lineage of MDR Mycobacterium tuberculosis in Bulgaria, 2007–2011
S. Panaiotov et al. (Volume 20, Number 11—November 2014)

Bacteria in Dairy Products in Baggage of Incoming Travelers, Brazil
C. Barros de Melo et al. (Volume 20, Number 11—November 2014)

Medscape CME Activity
Rapidly Growing Mycobacteria Associated with Laparoscopic Gastric Banding, Australia, 2005–2011
H.L. Wright et al. (Volume 20, Number 10—October 2014)

Mycobacterium tuberculosis Beijing Genotype Resistance to Transient Rifampin Exposure
A.L. den Hertog et al. (Volume 20, Number 11—November 2014)

Pulmonary Disease Caused by Mycobacterium marseillense, Italy
A. Grottola et al. (Volume 20, Number 10—October 2014)

Pulmonary Infection and Colonization with Nontuberculous Mycobacteria, Taiwan, 2000–2012
J.Y. Chien et al. (Volume 20, Number 8—August 2014)

Prevalence and Drug Resistance of Nontuberculous Mycobacteria, Northern China, 2008–2011
X. Wang et al. (Volume 20, Number 7—July 2014)

Possible Misidentification of Mycobacterium yongonense
S. Kuk Hong et al. (Volume 20, Number 6—June 2014)

Distinguishing Nontuberculous Mycobacteria from Multidrug-Resistant Mycobacterium tuberculosis, China
K. Xu et al. (Volume 20, Number 6—June 2014)

Treatment Practices, Outcomes, and Costs of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis, United States, 2005–2007
S.M. Marks et al. (Volume 20, Number 5—May 2014)

Regional Variation in Travel-related Illness acquired in Africa, March 1997–May 2011
M. Mendelson et al. (Volume 20, Number 4—April 2014)

High-level Relatedness among Mycobacterium abscessus subsp. massiliense Strains from Widely Separated Outbreaks
H. Tettelin et al. (Volume 20, Number 3—March 2014)

Medscape CME Activity
Use of Drug-Susceptibility Testing for Management of Drug-Resistant Tuberculosis, Thailand, 2004–2008
E. Lam et al. (Volume 20, Number 3—March 2014)

Minimal Diversity of Drug-Resistant Mycobacterium tuberculosis Strains, South Africa
N.R. Gandhi et al. (Volume 20, Number 3—March 2014)

Nontoxigenic tox-bearing Corynebacterium ulcerans Infection among Game Animals, Germany
T. Eisenberg et al. (Volume 20, Number 3—March 2014)

Buruli Ulcer in Liberia, 2012
K. Kollie et al. (Volume 20, Number 3—March 2014)

Concomitant Multidrug-resistant Pulmonary Tuberculosis and Susceptible Tuberculous Meningitis
C. Bernard et al. (Volume 20, Number 3—March 2014)

Quiet Moment around the Campfire
B. Breedlove (Volume 20, Number 6—June 2014)

I Am the Master of My Fate
S. Bloom (Volume 20, Number 3—March 2014)

Podcasts

Quiet Moment around the Campfire
B. Breedlove (Volume 20, Number 6—June 2014)

Additional Resources

Centers for Disease Control and PreventionWorld TB Day commemorates the discovery of the tuberculosis (TB) bacterium (Mycobacterium tuberculosis) by Dr. Robert Koch on March 24, 1882. World TB day is commemorated on this date each year to raise awareness among the public and policy makers that tuberculosis remains an epidemic in most parts of the world, and a public health problem in developed countries, causing the deaths of about one and a half million people each year. Koch's discovery opened the way towards diagnosing and curing TB.

World TB Day provides the opportunity to raise awareness about TB-related problems and solutions and to support worldwide TB-control efforts. While great strides have been made to control and cure TB, people still get sick and die from this disease in our country. Much more needs to be done to eliminate this disease.

The theme of World TB Day 2016 is “Unite to End TB.”

Click on the links to Emerging Infectious Diseases articles and podcasts below and learn more about the latest information and emerging trends in TB.

Articles

2016

Leveraging Advances in Tuberculosis Diagnosis and Treatment to Address Nontuberculous Mycobacterial Disease
R.M. Raju et al. (Volume 22, Number 3—March 2016)

Tuberculosis Caused by Mycobacterium africanum, United States, 2004–2013
A. Sharma et al. (Volume 22, Number 3—March 2016)

Patient Report and Review of Rapidly Growing Mycobacterial Infection after Cardiac Device Implantation
V.K. Phadke et al. (Volume 22, Number 3—March 2016)

Improved Detection of Tuberculosis and Multidrug-Resistant Tuberculosis among Tibetan Refugees, India
K.L. Dierberg et al. (Volume 22, Number 3—March 2016)

Factors Associated with Loss to Follow-up during Treatment for Multidrug-Resistant Tuberculosis, the Philippines, 2012–2014
T.E. Tupasi et al. (Volume 22, Number 3—March 2016)

Use of Transnational Services to Prevent Treatment Interruption in Tuberculosis-Infected Persons Who Leave the United States
C.A. Tschampl et al. (Volume 22, Number 3—March 2016)

Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia
H.R. Stagg et al. (Volume 22, Number 3—March 2016)

Effects of Response to 2014–2015 Ebola Outbreak on Deaths from Malaria, HIV/AIDS, and Tuberculosis, West Africa
A.S. Parpia et al. (Volume 22, Number 3—March 2016)

Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009–2014
B. Henry et al. (Volume 22, Number 3—March 2016)

Treatment of Mycobacterium abscessus Infection
S.A. Novosad et al. (Volume 22, Number 3—March 2016)

Tuberculosis, Fiji, 2002–2013
L. Pezzoli et al. (Volume 22, Number 3—March 2016)

Medscape CME Activity
Epidemiology of Human Mycobacterium bovis Disease, California, USA, 2003–2011
M. Gallivan et al. (Volume 21, Number 3—March 2015)

Patient Diagnostic Rate as Indicator of Tuberculosis Case Detection, South Africa
M.M. Claassens et al. (Volume 22, Number 3—March 2016)

Far East Scarlet-Like Fever Caused by a Few Related Genotypes of Yersinia pseudotuberculosis, Russia
N.F. Timchenko et al. (Volume 22, Number 3—March 2016)

Monitoring Therapy Compliance of Tuberculosis Patients by using Video-Enabled Electronic Devices
A. Story et al. (Volume 22, Number 3—March 2016)

High Tuberculosis Risk among Medical Trainees, Pune, India
A. Basavaraj et al. (Volume 22, Number 3—March 2016)

Mycobacterium microti Infection in Dairy Goats, France
L. Michelet et al. (Volume 22, Number 3—March 2016)

Mycobacterium orygis–Associated Tuberculosis in Free-Ranging Rhinoceros, Nepal, 2015
J. Thapa et al. (Volume 22, Number 3—March 2016)

Mycobacterium arupense as an Emerging Cause of Tenosynovitis
F. Krapp Lopez et al. (Volume 22, Number 3—March 2016)

Depictions of Heroism in Battle and Anguish from Tuberculosis
T. Chorba et al. (Volume 22, Number 3—March 2016)

Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis
J. Furin et al. (Volume 22, Number 3—March 2016)

Global Introduction of New Multidrug-Resistant Tuberculosis Drugs—Balancing Regulation with Urgent Patient Needs
T. Sullivan et al. (Volume 22, Number 3—March 2016)

African Buffalo Movement and Zoonotic Disease Risk across Transfrontier Conservation Areas, Southern Africa
A. Caron et al. (Volume 22, Number 2—February 2016)

2015

Achievements in and Challenges of Tuberculosis Control in South Korea
J. Han Kim et al. (Volume 21, Number 11—November 2015)

Epidemiology of Primary Multidrug-Resistant Tuberculosis, Vladimir Region, Russia
J.V. Ershova et al. (Volume 21, Number 11—November 2015)

Histoplasmosis in HIV-Infected Persons, Yaoundé, Cameroon
C.E. Mandengue et al. (Volume 21, Number 11—November 2015)

Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen
J. Achar et al. (Volume 21, Number 11—November 2015)

Mycobacterium sherrisii Pulmonary Disease, Burkina Faso
E. Borroni et al. (Volume 21, Number 11—November 2015)

Co-infection with Drug-Susceptible and Reactivated Latent Multidrug-Resistant Mycobacterium tuberculosis
L. Pérez-Lago et al. (Volume 21, Number 11—November 2015)

Increase in Lymphadenitis Cases after Shift in BCG Vaccine Strain
G. Kuchukhidze et al. (Volume 21, Number 9—September 2015)

Risk for Mycobacterial Disease among Patients with Rheumatoid Arthritis, Taiwan, 2001–2011
T.L. Liao et al. (Volume 21, Number 8—August 2015)

Seasonal Patterns of Buruli Ulcer Incidence, Central Africa, 2002–2012
J. Landier et al. (Volume 21, Number 8—August 2015)

Multidrug-Resistant Tuberculosis in Patients for Whom First-Line Treatment Failed, Mongolia, 2010–2011
C.C. Dobler et al. (Volume 21, Number 8—August 2015)

Fatal Nosocomial MDR TB Identified through Routine Genetic Analysis and Whole-Genome Sequencing
O.M. Williams et al. (Volume 21, Number 6—June 2015)

Multidrug-Resistant Tuberculosis in Europe, 2010–2011
G. Günther et al. (Volume 21, Number 3—March 2015)

Prisons as Reservoir for Community Transmission of Tuberculosis, Brazil
F.P.C. Sacchi et al. (Volume 21, Number 3—March 2015)

Increased Risk for Multidrug-Resistant Tuberculosis in Migratory Workers, Armenia
N. Truzyan et al. (Volume 21, Number 3—March 2015)

Characteristics of Tuberculosis Cases that Started Outbreaks in the United States, 2002–2011
M.B. Haddad et al. (Volume 21, Number 3—March 2015)

Moxifloxacin Prophylaxis Against MDR TB, New York, New York, USA
L. Trieu et al. (Volume 21, Number 3—March 2015)

Noninvasive Test for Tuberculosis Detection among Primates
T.M. Wolf et al. (Volume 21, Number 3—March 2015)

Buruli Ulcer in Traveler from Suriname, South America, to the Netherlands
W.R. Faber et al. (Volume 21, Number 3—March 2015)

Tuberculosis Microepidemics among Dispersed Migrants, Birmingham, UK, 2004–2013
M.L. Munang et al. (Volume 21, Number 3—March 2015)

Spillover of Mycobacterium bovis from Wildlife to Livestock, South 
Africa
J. Musoke et al. (Volume 21, Number 3—March 2015)

Mycobacterium bovis Infection in Humans and Cats in Same Household, Texas, USA, 2012
K.E.F. Ramdas et al. (Volume 21, Number 3—March 2015)

Red Deer as Maintenance Host for Bovine Tuberculosis, Alpine Region
M. Fink et al. (Volume 21, Number 3—March 2015)

Role of Race/Ethnicity in Pulmonary Nontuberculous Mycobacterial Disease
B.S. Thomas et al. (Volume 21, Number 3—March 2015)

Treatment of Mycobacterium abscessus subsp. massiliense Tricuspid Valve Endocarditis
R.G. Huth et al. (Volume 21, Number 3—March 2015)

Disseminated Mycobacterium tuberculosis in Imported Sooty Mangabey, Thailand
S. Kesdangsakonwut et al. (Volume 21, Number 3—March 2015)

Mycobacterium bovis BCG–Associated Osteomyelitis/Osteitis, Taiwan
N.C. Chiu et al. (Volume 21, Number 3—March 2015)

Multidrug-Resistant Tuberculosis Outbreak in Gaming Centers, Singapore, 2012
C.B.E. Chee et al. (Volume 21, Number 1—January 2015)

2014

HIV-Associated Disseminated Emmonsiosis, Johannesburg, South Africa
W.G. van Hougenhouck-Tulleken et al. (Volume 20, Number 12—December 2014)

Beijing Lineage of MDR Mycobacterium tuberculosis in Bulgaria, 2007–2011
S. Panaiotov et al. (Volume 20, Number 11—November 2014)

Bacteria in Dairy Products in Baggage of Incoming Travelers, Brazil
C. Barros de Melo et al. (Volume 20, Number 11—November 2014)

Medscape CME Activity
Rapidly Growing Mycobacteria Associated with Laparoscopic Gastric Banding, Australia, 2005–2011
H.L. Wright et al. (Volume 20, Number 10—October 2014)

Mycobacterium tuberculosis Beijing Genotype Resistance to Transient Rifampin Exposure
A.L. den Hertog et al. (Volume 20, Number 11—November 2014)

Pulmonary Disease Caused by Mycobacterium marseillense, Italy
A. Grottola et al. (Volume 20, Number 10—October 2014)

Pulmonary Infection and Colonization with Nontuberculous Mycobacteria, Taiwan, 2000–2012
J.Y. Chien et al. (Volume 20, Number 8—August 2014)

Prevalence and Drug Resistance of Nontuberculous Mycobacteria, Northern China, 2008–2011
X. Wang et al. (Volume 20, Number 7—July 2014)

Possible Misidentification of Mycobacterium yongonense
S. Kuk Hong et al. (Volume 20, Number 6—June 2014)

Distinguishing Nontuberculous Mycobacteria from Multidrug-Resistant Mycobacterium tuberculosis, China
K. Xu et al. (Volume 20, Number 6—June 2014)

Treatment Practices, Outcomes, and Costs of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis, United States, 2005–2007
S.M. Marks et al. (Volume 20, Number 5—May 2014)

Regional Variation in Travel-related Illness acquired in Africa, March 1997–May 2011
M. Mendelson et al. (Volume 20, Number 4—April 2014)

High-level Relatedness among Mycobacterium abscessus subsp. massiliense Strains from Widely Separated Outbreaks
H. Tettelin et al. (Volume 20, Number 3—March 2014)

Medscape CME Activity
Use of Drug-Susceptibility Testing for Management of Drug-Resistant Tuberculosis, Thailand, 2004–2008
E. Lam et al. (Volume 20, Number 3—March 2014)

Minimal Diversity of Drug-Resistant Mycobacterium tuberculosis Strains, South Africa
N.R. Gandhi et al. (Volume 20, Number 3—March 2014)

Nontoxigenic tox-bearing Corynebacterium ulcerans Infection among Game Animals, Germany
T. Eisenberg et al. (Volume 20, Number 3—March 2014)

Buruli Ulcer in Liberia, 2012
K. Kollie et al. (Volume 20, Number 3—March 2014)

Concomitant Multidrug-resistant Pulmonary Tuberculosis and Susceptible Tuberculous Meningitis
C. Bernard et al. (Volume 20, Number 3—March 2014)

Quiet Moment around the Campfire
B. Breedlove (Volume 20, Number 6—June 2014)

I Am the Master of My Fate
S. Bloom (Volume 20, Number 3—March 2014)

Podcasts

Quiet Moment around the Campfire
B. Breedlove (Volume 20, Number 6—June 2014)

Additional Resources

Centers for Disease Control and Prevention